|
一、项目概况：
1、主要产品及生产规模：年产500万瓶参芪沙棘合剂
2、产品特点：该产品是中国长白山纯天然药用植物制剂，含有多种纯天然抗氧化剂。经吉林省中医中药研究院的基础研究，白求恩医科大学和长春中医学院附属医院的临床研究 、中国人民解放军冰上训练基地的运动员试用，结果表明：本品能激活氧化脂质等毒素；促进性腺分泌，提高性功能血红蛋白和肌红蛋白的含量，提高心脑组织的供氧能力。是延缓衰老、提高体能、增强耐力、消除疲劳的中药新药。
3、项目市场情况分析：由吉林市葆龄药业有限公司研究、生产的系列产品之一的葆龄康(液)，于1996年获北京国际发明金奖，1997年被认定为吉林省级新产品，达到国内先进水平。同时对于运动员而言，即能提高运动员成绩，又不含国际奥委会规定的违禁药物。“葆龄”系列产品除“葆龄康”外还有功能食品、功能饮品。并且不同功能的产品适应不同的消费群体。尤其我国加入WTO后，纯天然植物制品将有一定的竞争力，所以本产品有广阔的潜在市场。目前产品供不应求，急需扩大生产规模。
4、投资总额：500万美元
5、占地面积：10,000平方米，建筑面积5,000平方米。其中GMP标准厂房约3,000平方米
6、中外方投资比例：协商，外方出资400万美元，最大可占80%。中方投入中药新药技术、制药工业产权等无形资产，外方投入建设GMP药厂建设资金和流动资金。
7、合作方式：合资
8、经济效益分析：销售收入：2800万美元税金：460万美元
利润：760万美元投资回收期：1.5年
9、拟建项目选址：吉林高新技术产业开发区内
10、项目进展情况：已经通过吉林高新区立项和吉林省计委立项。
二、中方企业情况：
1、企业名称：吉林市葆龄药业有限责任公司私营
2、企业基本情况：
注册资本：6.2万美元总资产：155万美元
职工总数：20人，其中科技人员14人(高级职称7人)
3、主要产品及产量：年产10万瓶“葆龄康”口服液
4、企业现有技术水平：由吉林市葆龄药业有限公司研究、生产的系列产品之一的葆龄康(液)，于1996年获北京国际发明金奖，1997年被认定为吉林省级新产品，其技术水平达到国内先进水平。
三、联系方式：
单位：吉林市江城网站
联系人：马天作
手机：013514426560
地址：吉林市北京路142号
邮编：132011
电话：86-432-2014042、2014043
传真：86-432-2014044
Http://www.jiangcheng.net
E-mail: web@jiangcheng.net
Project of Chinese Medicine-Mixture of Ginseng, Astragalus Membranous and Thorn Industrialization
1. Description of the proposed project
1-1. Main product and scale of production: Annual output 5 million bottles of Medicine-Mixture of Ginseng, Astragalus Membranous and Thorn
1-2. Characteristics of the product: Containing varieties of natural antioxidant, this product is a pure natural galenical discovered in Changbai Mountain of China. The basic studies conducted by Chinese Medicine Research Institute of Jilin Province and the trial application by the athletes of China Liberation Army Skate Training Base show that Baoling Kang Oral Liquid has the following functions: Activate the activity of super oxide divergent enzyme and glutathione peroxide; enzyme of human body, timely clear away the toxin like free radical and peroxide lipid; Promote the secretion of sex gland and raise the sexual function; Increase the content of haemoglobin and myogen, enlarge the oxygen feed to cardiovascular and cerebrovascular system.
1-3. Proposed market prospect: Baolingkang Oral Liquid, one of the serial products invented and produced by Jilin City Baoling Pharmaceutical Company, has won the Beijing Gold Metal of international Invention in 1996 and been accepted as the Provincial New Product by Jilin province in 1997. This product is a new Chinese medicine to prolong lifespan, buildup physical strength, raise stamina and reduce fatigue for human body. Baoling Company needs to build their GMP workshop in jilin National High-tech Zone, besides Baolingkang oral liquid, Baoling serial product also includes functional products of food and drink. With the wide variety of types and prices, this serial products meet the variable needs of the consumers. After the accession of the WTO, the pure natural galenical will have a great market prospect. The output of this product now cannot satisfy the huge market demand, so it is urgent to enlarge its scale of production.
1-4. Total investment: 5 million in US dollars.
1-5 Land Coverage: 10,000 square meters, building area: 5000 square meters, inclusive of 3000 square meters of GMP standard plants.
1-6. Proposed ownership structure: negotiable. Foreign invest $ 4million includes expenses for factory building and working capital, local company invest invisible assets includes production know-how and property right.
1-7. Form of Cooperation: Equity joint venture.
1-8. Economic benefit analysis: Annual sales: 28 Million in US dollars; annual tax: 4.6million in US dollars; annual profit: 7.6 million in US dollars; pay back period:1.5 years.
1-9. Project site: Jilin Hi-tech Industrial Development Zone.
1-10. Proceeding of the project: The project has been approved by Jilin Hi-tech Zone and Jilin Provincial Planning Committee.
2. Description of Chinese partner
2-1. Company name: Jilin city Baoling Pharmaceutical Co., Ltd. (Private Company)
2-2. Company data: Registered capital: US$62,000; total property value: 1.55 Million in US dollars;
number of staff and workers: 20; number of technicians: 14, inclusive of 7 senior titles.
2-3. Main product and scale of production: Annual output 100 thousand bottles of Baolingkang oral liquid.
2-4. Existing technical level: 1996, ranked 1st of Beijing International Inventions;
1997, listed in provincial level new products.
3. Contact mode
Company: JiLin City JiangCheng Network
Name: Ma Tianzuo
Mobile: 013514426560
Address: No.142 BeiJing Road in JiLin City
P.C.: 132013
Tel: 86-432- 2014042、2014043
Fax: 86-432-2014044
Http://www.jiangcheng.net
E-mail: web@jiangcheng.net
| 
